Author page: Kathrin Folkendt

Gameto Secures $33M in Series B Funding to Advance Novel In Vitro Fertilization Treatments

Gameto, a biotech firm dedicated to women’s health, has announced the successful closure of a $33 million Series B financing round. This round, which exceeded initial targets, was led by Two Sigma Ventures and RA Capital, with participation from existing investors such as Insight Partners, Future Ventures, and BOLD Capital Partners. New investors include Olivia Walton’s Ingeborg Investments, Stacey Bendet Eisner, and…

Seek Launches First At-Home Test for Alcohol’s Effects on Women’s Health

Healthtech startup Seek has launched the first at-home lab test specifically designed to measure the impact of alcohol on women’s health. Founder Katie Garry’s inspiration for Seek stemmed from personal experiences. Recognizing the lack of resources for women who want to continue drinking while taking care of their health, Seek aims to fill this void by offering a test that measures biomarkers…

What’s New in Femtech This Week? (May 23, 2024)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Amplexd Therapeutics secures $2M to advance HPV-induced cervical precancer treatments. Estonian maternity startups CARA Health secures €620K for German expansion. Hinge Health adds movement-based menopause support to…

The Biggest Women’s Health Investment Opportunities, According to Women’s Health Investors

Image: NYSE You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.

BII & Science Journals Launch Translational Medicine Prize for Innovations in Women’s Health and Gender Medicine

The BioInnovation Institute (BII), an international non-profit foundation dedicated to incubating and accelerating world-class life science research, has unveiled the BII & Science Translational Medicine Prize for Innovations in Women’s Health and Gender Medicine. This new prize builds upon the success of the BII & Science Prize for Innovation, now in its third year. It aims to recognize and celebrate researchers globally…

European Femtech Sector Poised for Growth, Sie Ventures Report Reveals

The femtech landscape in Europe is on a trajectory to achieve a market valuation of $35 billion by 2032, signaling a significant period of growth and development. This promising outlook is highlighted in the latest report from Sie Ventures, which draws on data from more than 540 active femtech companies across Europe. The United Kingdom leads as Europe’s epicenter for women’s health…

Bayer and Hologic Partner to Advance Breast Cancer Detection with Contrast-Enhanced Mammography

Bayer and Hologic have announced a collaboration to introduce a solution for contrast-enhanced mammography (CEM), a technique enhancing breast tissue visualization for improved breast cancer detection and treatment guidance. Contrast-enhanced mammography is a breast imaging modality aiding in breast cancer diagnosis. By integrating Hologic’s mammography technologies with Bayer’s contrast delivery system, the MEDRAD Stellant FLEX Computed Tomography (CT) Injection System, the collaboration…

How Astek Diagnostics Is Transforming UTI Identification and Treatment with Rapid Testing Technology

Astek Diagnostics, founded by Mustafa Al-Adhami, PhD in response to his grandfather’s experience with a urinary tract infection (UTI), is on a mission to transform diagnostic procedures. Witnessing his grandfather’s suffering, Al-Adhami recognized the urgent need for a more efficient and precise diagnostic solution. Thus, he conceived the idea of the Jiddu Analyzer, aimed at providing rapid antibiotic sensitivity testing within one…